| GILD |
Gilead Sciences, Inc. |
115.37B |
5.28% |
|
|
|
|
|
92.57 |
1.62% |
36.85% |
46.92% |
|---|
| NTRA |
Natera, Inc. |
21.37B |
5.09% |
|
|
|
|
|
161.88 |
2.40% |
55.75% |
34.05% |
|---|
| UTHR |
United Therapeutics Corporation |
16.05B |
5.04% |
|
|
|
|
|
359.58 |
-0.16% |
N/A |
N/A |
|---|
| ILMN |
Illumina, Inc. |
21.57B |
4.89% |
|
|
|
|
|
136.02 |
1.51% |
45.78% |
35.98% |
|---|
| INCY |
Incyte Corporation |
13.26B |
4.84% |
|
|
|
|
|
68.84 |
2.65% |
52.75% |
75.41% |
|---|
| REGN |
Regeneron Pharmaceuticals, Inc. |
75.85B |
4.84% |
|
|
|
|
|
701.85 |
-0.90% |
34.78% |
72.04% |
|---|
| BIIB |
Biogen Inc. |
21.34B |
4.77% |
|
|
|
|
|
146.47 |
-0.62% |
33.95% |
70.80% |
|---|
| AMGN |
Amgen Inc. |
141.58B |
4.63% |
|
|
|
|
|
263.38 |
0.84% |
25.97% |
20.88% |
|---|
| EXAS |
Exact Sciences Corporation |
10.99B |
3.04% |
|
|
|
|
|
59.40 |
5.86% |
56.47% |
43.25% |
|---|
| NBIX |
Neurocrine Biosciences, Inc. |
13.71B |
3.00% |
|
|
|
|
|
135.42 |
0.34% |
36.61% |
2.44% |
|---|
| BCRX |
BioCryst Pharmaceuticals, Inc. |
1.57B |
2.93% |
|
|
|
|
|
7.57 |
2.44% |
60.58% |
33.98% |
|---|
| SRPT |
Sarepta Therapeutics, Inc. |
11.36B |
2.92% |
|
|
|
|
|
118.97 |
-0.42% |
41.48% |
17.53% |
|---|
| QGEN |
Qiagen N.V. |
9.91B |
2.91% |
|
|
|
|
|
44.67 |
0.79% |
32.43% |
58.64% |
|---|
| ACAD |
ACADIA Pharmaceuticals Inc. |
2.81B |
2.87% |
|
|
|
|
|
16.87 |
0.84% |
53.83% |
32.25% |
|---|
| MNKD |
MannKind Corporation |
1.89B |
2.87% |
|
|
|
|
|
6.85 |
8.73% |
64.11% |
41.80% |
|---|
| BMRN |
BioMarin Pharmaceutical Inc. |
12.51B |
2.84% |
|
|
|
|
|
65.66 |
1.02% |
36.49% |
36.43% |
|---|
| CPRX |
Catalyst Pharmaceuticals, Inc. |
2.54B |
2.83% |
|
|
|
|
|
21.27 |
-0.89% |
44.52% |
23.42% |
|---|
| VCYT |
Veracyte, Inc. |
3.17B |
2.80% |
|
|
|
|
|
40.89 |
4.66% |
77.20% |
38.59% |
|---|
| TECH |
Bio-Techne Corporation |
11.63B |
2.77% |
|
|
|
|
|
73.17 |
2.49% |
30.88% |
36.60% |
|---|
| HALO |
Halozyme Therapeutics, Inc. |
5.97B |
2.77% |
|
|
|
|
|
46.96 |
-0.76% |
45.48% |
38.93% |
|---|
| COLL |
Collegium Pharmaceutical, Inc. |
957.83M |
2.72% |
|
|
|
|
|
29.70 |
-2.43% |
125.13% |
63.91% |
|---|
| BPMC |
Blueprint Medicines Corporation |
5.73B |
2.71% |
|
|
|
|
|
90.14 |
1.36% |
56.46% |
30.27% |
|---|
| RPRX |
Royalty Pharma plc |
11.07B |
2.65% |
|
|
|
|
|
24.92 |
2.64% |
30.67% |
33.89% |
|---|
| AXSM |
Axsome Therapeutics, Inc. |
4.40B |
2.62% |
|
|
|
|
|
90.73 |
1.10% |
117.03% |
96.34% |
|---|
| TGTX |
TG Therapeutics, Inc. |
5.01B |
2.62% |
|
|
|
|
|
32.20 |
4.04% |
85.53% |
58.29% |
|---|
| XNCR |
Xencor, Inc. |
1.69B |
2.61% |
|
|
|
|
|
24.13 |
0.50% |
97.87% |
20.59% |
|---|
| EXEL |
Exelixis, Inc. |
9.51B |
2.58% |
|
|
|
|
|
33.29 |
-1.16% |
38.11% |
33.80% |
|---|
| PTGX |
Protagonist Therapeutics, Inc. |
2.47B |
2.57% |
|
|
|
|
|
41.49 |
4.93% |
68.97% |
27.99% |
|---|
| CDNA |
CareDx, Inc |
1.11B |
2.41% |
|
|
|
|
|
20.61 |
0.29% |
100.64% |
36.46% |
|---|
| MYGN |
Myriad Genetics, Inc. |
1.22B |
2.40% |
|
|
|
|
|
13.36 |
1.44% |
47.92% |
77.50% |
|---|
| AGPXX |
Invesco Government & Agency Portfolio |
|
0.21% |
|
|
|
|
|
|
|
|
|
|---|